One of the most serious threats to public health worldwide is posed by antibiotic-resistant pathogens. The World Health Organization (WHO) warns of the imminent beginning of a post-antibiotic era in which harmless infections ...
Cell & Microbiology
Oct 29, 2019
0
6
Scientists from Rutgers University and around the world have discovered an antibiotic produced by a soil bacterium from a Mexican tropical forest that may help lead to a "plant probiotic," more robust plants and other antibiotics.
Cell & Microbiology
Oct 8, 2019
0
1242
A deadly, antibiotic-resistant bacterium can be sterilized by hijacking its heme-acquisition system, which is essential for its survival. The new strategy, developed by Nagoya University researchers and colleagues in Japan, ...
Biochemistry
Sep 18, 2019
0
10
Craig MacLean, Professor of Evolution and Microbiology at Oxford's Department of Zoology, explains how evolutionary biology can help us to get rid of antibiotic resistant bacteria.
Cell & Microbiology
Sep 16, 2019
0
5
Antibiotic resistance is one of the biggest public health challenges in the world today since many common bacterial infections are developing resistance to the drugs once used to treat them, and new antibiotics aren't being ...
Plants & Animals
Sep 15, 2019
0
665
Bacterial leaf streak, a foliar disease in corn, has only been in the United States for a handful of years, but Tiffany Jamann says it's a major problem in the Western Corn Belt.
Plants & Animals
Sep 11, 2019
0
17
Steadily and relentlessly, the bacterium that causes gonorrhea has slipped past medicine's defenses, acquiring resistance to once-reliable drugs, including penicillin, tetracycline, and ciprofloxacin. These former stalwarts ...
Biochemistry
Aug 23, 2019
0
124
May 30—Our cells' process for transforming genes into useful proteins works much like an automobile factory's assembly line; there are schematics, parts, workers, motors, quality control systems and even recycling crews. ...
Cell & Microbiology
May 30, 2019
0
126
A growing number of infections—such as pneumonia, gonorrhea and tuberculosis—are becoming harder to treat, as bacteria evolve defenses against antibiotics faster than we can develop new drugs to replace them.
Cell & Microbiology
May 16, 2019
0
54
A KAIST research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours. This chip can be a cell-based drug screening platform for exploring ...
Biochemistry
Apr 19, 2019
0
10
